Simulating The Long-term Health Economic Impact Of Overweight And Obesity In Australia And Identifying Cost-effective Treatment Or Prevention Strategies
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Increasing levels of obesity in Australia negatively impact on health and at considerable cost to the health system. Recent availability of large individual-level health datasets enables us to develop a better understanding of weight gain on the progression of obesity related co-morbidities, mortality and healthcare costs. This fellowship provides much-needed evidence on obesity interventions and its impact on long-term costs and benefits in Australia to inform future obesity related policies.
Optimising Value And Equity In Access To Prescribed Medicines
Funder
National Health and Medical Research Council
Funding Amount
$371,052.00
Summary
The strong opposition to the Federal government’s proposed increase in out-of-pocket healthcare costs in the 2014 budget demonstrates the significance of value-for-money healthcare to the Australian public. Using information from Canada and Australia, this study will help patients, regardless of socioeconomic status, to access the medicines they need in a way that is affordable for individuals and governments, resulting in wise and fair medicine use within the Australian healthcare system.
Eliminating HCV: Statistical Modelling And Health Economic Evaluation In The New DAA Era
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
While new generation hepatitis C virus (HCV) treatments are highly efficacious, their high cost means multi-pronged approaches will be needed to reach elimination targets. This project will use statistical and mathematical modelling to inform real world health economic evaluations determine the most cost-effective response. This will inform health policy in Australia and globally.
The Value Of Osteoporosis Interventions: Evaluating The Cost-effectiveness And Incorporating Patients’ Preference
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Osteoporosis (OP) poses substantial disease and economic burden. Many medications are publicly available and subsidized in Australia, and many new medications are on the horizon. Their value for money, however, is questionable without solid health economic evidence. In addition, patient preference for OP treatment is not well understood. My project is to develop a global health economics model to identify cost-effective treatments, and to elicit patient preference for different OP treatments.
Defining Burden And Drivers Of Antibiotic Resistant Bacteria And Healthcare Infections To Plan Cost-effective Interventions
Funder
National Health and Medical Research Council
Funding Amount
$340,891.00
Summary
I am an Infectious Diseases physician and early career researcher with interests in drug resistant infections and hospital infections. The research program will describe the threat of drug-resistant infections by demonstrating which superbugs have the greatest impact and by describing how these bacteria disperse through our health system. The research will evaluate and prioritise strategies to confront these problems.
New Approaches To Describing And Valuing Quality Of Life
Funder
National Health and Medical Research Council
Funding Amount
$304,596.00
Summary
The ability of healthcare to improve quality of life is a major factor in determining public subsidy. This fellowship first explores patterns in Australian quality of life. This will identify groups with poor quality of life, and the remedying impact achieved under various interventions. It will then consider how people place value on aspects of quality of life. The two strands will allow linkage between important areas of quality of life and the policy impact of health interventions.
Reducing The Burden Of Cancer In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$257,561.00
Summary
Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcome ....Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcomes in patients with CKD.Read moreRead less
Towards Evidence-based Adoption And Scale-up Of Cost-saving Primary Health Care Innovations
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
What innovations like service integration, care coordination and information technology (e.g. text message reminders, remote video consultations, remote monitoring) have in common is that they alter the patient-provider interface, more reliably and consistently than improving clinical outcomes. So, to determine their true costs and benefits, how to select among them and how to scale them up, this research program will assess them based on measures of how they alter patient-provider transactions.